Summary: In this podcast, we speak with UBS Asset Management?s Healthcare and Biotech portfolio manager, Matt Konosky, and equity investment specialist, Tom Digenan, on COVID and the race for a vaccine. When should we expect to see a vaccine and some semblance of normalcy? When will we know the vaccines are safe? What?s UBS Asset Management?s outlook on the Healthcare and Biotech sectors? Host: Daniel Cassidy
